US Stock MarketDetailed Quotes

CHRO Chromocell Therapeutics

Watchlist
  • 0.630
  • -0.001-0.16%
Close Nov 18 16:00 ET
  • 0.630
  • 0.0000.00%
Post 16:03 ET
3.80MMarket Cap-364P/E (TTM)

Chromocell Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
30.84%-177.91K
-1,424.85%-2.95M
-1,048.93%-1.99M
37.40%-981.03K
46.48%-356.81K
0.22%-257.24K
33.56%-193.62K
50.65%-173.37K
1.62%-1.57M
-114.48%-666.62K
Net income from continuing operations
-19.20%-1.69M
-85.83%-1.77M
-165.10%-2.56M
-200.20%-7.38M
-221.22%-4.04M
-155.41%-1.42M
-185.39%-953.35K
-211.34%-966.56K
-312.94%-2.46M
-498.87%-1.26M
Other non cash items
-478.27%-352.79K
--0
1,813.52%605.63K
177.52%389.72K
184.74%121.33K
146.65%93.26K
283.60%143.47K
40.01%31.65K
--140.43K
--42.61K
Change In working capital
85.54%1.35M
-667.56%-1.64M
-166.98%-327.75K
220.05%2.05M
24.19%544.04K
179.18%728.8K
5,406.33%288.92K
870.74%489.32K
184.79%640.86K
534.39%438.05K
-Change in prepaid assets
--63.52K
--62.83K
---220.93K
----
----
--0
--0
--0
----
----
-Change in payables and accrued expense
179.73%2.04M
-689.30%-1.7M
-121.83%-106.82K
220.05%2.05M
24.19%544.04K
351.67%728.8K
3,480.14%288.92K
1,365.74%489.32K
177.43%640.86K
534.39%438.05K
Cash from discontinued investing activities
Operating cash flow
30.84%-177.91K
-1,424.85%-2.95M
-1,048.93%-1.99M
37.40%-981.03K
46.48%-356.81K
0.22%-257.24K
33.56%-193.62K
50.65%-173.37K
1.62%-1.57M
-114.48%-666.62K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-590.74%-972.28K
599.54%1.59M
3,294.63%5.67M
-36.98%1.02M
-21.52%430.41K
-53.78%198.13K
-22.77%226.91K
-52.49%166.9K
1.83%1.62M
76.46%548.45K
Net issuance payments of debt
-552.88%-897.28K
599.54%1.59M
-228.67%-214.76K
91.73%766.94K
75.00%175K
--198.13K
--226.91K
-44.37%166.9K
--400K
--100K
Net common stock issuance
---75K
--0
--5.88M
--255.41K
--255.41K
--0
--0
--0
--0
----
Net other financing activities
----
----
----
----
----
----
----
----
-23.28%1.22M
44.28%448.45K
Cash from discontinued financing activities
Financing cash flow
-590.74%-972.28K
599.54%1.59M
3,294.63%5.67M
-36.98%1.02M
-21.52%430.41K
-53.78%198.13K
-22.77%226.91K
-52.49%166.9K
1.83%1.62M
76.46%548.45K
Net cash flow
Beginning cash position
2,836.88%2.41M
7,656.40%3.77M
75.02%96.39K
--55.07K
-86.85%22.79K
3,330.79%81.89K
--48.61K
--55.07K
--0
--173.24K
Current changes in cash
-1,845.95%-1.15M
-4,201.34%-1.37M
56,917.79%3.67M
-24.98%41.32K
162.29%73.61K
-134.60%-59.11K
--33.29K
---6.47K
--55.07K
---118.17K
End cash Position
5,407.34%1.25M
2,836.88%2.41M
7,656.40%3.77M
75.02%96.39K
75.02%96.39K
-86.85%22.79K
3,330.79%81.89K
--48.61K
--55.07K
--55.07K
Free cash flow
30.84%-177.91K
-1,424.85%-2.95M
-1,048.93%-1.99M
37.40%-981.03K
46.48%-356.81K
0.22%-257.24K
33.56%-193.62K
50.65%-173.37K
1.62%-1.57M
-114.48%-666.62K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 30.84%-177.91K-1,424.85%-2.95M-1,048.93%-1.99M37.40%-981.03K46.48%-356.81K0.22%-257.24K33.56%-193.62K50.65%-173.37K1.62%-1.57M-114.48%-666.62K
Net income from continuing operations -19.20%-1.69M-85.83%-1.77M-165.10%-2.56M-200.20%-7.38M-221.22%-4.04M-155.41%-1.42M-185.39%-953.35K-211.34%-966.56K-312.94%-2.46M-498.87%-1.26M
Other non cash items -478.27%-352.79K--01,813.52%605.63K177.52%389.72K184.74%121.33K146.65%93.26K283.60%143.47K40.01%31.65K--140.43K--42.61K
Change In working capital 85.54%1.35M-667.56%-1.64M-166.98%-327.75K220.05%2.05M24.19%544.04K179.18%728.8K5,406.33%288.92K870.74%489.32K184.79%640.86K534.39%438.05K
-Change in prepaid assets --63.52K--62.83K---220.93K----------0--0--0--------
-Change in payables and accrued expense 179.73%2.04M-689.30%-1.7M-121.83%-106.82K220.05%2.05M24.19%544.04K351.67%728.8K3,480.14%288.92K1,365.74%489.32K177.43%640.86K534.39%438.05K
Cash from discontinued investing activities
Operating cash flow 30.84%-177.91K-1,424.85%-2.95M-1,048.93%-1.99M37.40%-981.03K46.48%-356.81K0.22%-257.24K33.56%-193.62K50.65%-173.37K1.62%-1.57M-114.48%-666.62K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -590.74%-972.28K599.54%1.59M3,294.63%5.67M-36.98%1.02M-21.52%430.41K-53.78%198.13K-22.77%226.91K-52.49%166.9K1.83%1.62M76.46%548.45K
Net issuance payments of debt -552.88%-897.28K599.54%1.59M-228.67%-214.76K91.73%766.94K75.00%175K--198.13K--226.91K-44.37%166.9K--400K--100K
Net common stock issuance ---75K--0--5.88M--255.41K--255.41K--0--0--0--0----
Net other financing activities ---------------------------------23.28%1.22M44.28%448.45K
Cash from discontinued financing activities
Financing cash flow -590.74%-972.28K599.54%1.59M3,294.63%5.67M-36.98%1.02M-21.52%430.41K-53.78%198.13K-22.77%226.91K-52.49%166.9K1.83%1.62M76.46%548.45K
Net cash flow
Beginning cash position 2,836.88%2.41M7,656.40%3.77M75.02%96.39K--55.07K-86.85%22.79K3,330.79%81.89K--48.61K--55.07K--0--173.24K
Current changes in cash -1,845.95%-1.15M-4,201.34%-1.37M56,917.79%3.67M-24.98%41.32K162.29%73.61K-134.60%-59.11K--33.29K---6.47K--55.07K---118.17K
End cash Position 5,407.34%1.25M2,836.88%2.41M7,656.40%3.77M75.02%96.39K75.02%96.39K-86.85%22.79K3,330.79%81.89K--48.61K--55.07K--55.07K
Free cash flow 30.84%-177.91K-1,424.85%-2.95M-1,048.93%-1.99M37.40%-981.03K46.48%-356.81K0.22%-257.24K33.56%-193.62K50.65%-173.37K1.62%-1.57M-114.48%-666.62K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data